David Préfontaine

2.0k total citations
16 papers, 721 citations indexed

About

David Préfontaine is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Préfontaine has authored 16 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Préfontaine's work include Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and IL-33, ST2, and ILC Pathways (5 papers). David Préfontaine is often cited by papers focused on Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and IL-33, ST2, and ILC Pathways (5 papers). David Préfontaine collaborates with scholars based in Canada and United Kingdom. David Préfontaine's co-authors include Qutayba Hamid, Susan Foley, James G. Martin, Andrew J. Halayko, Ron Olivenstein, Catherine Lemière, Séverine Audusseau, Stéphane Lajoie-Kadoch, Esther Dajczman and Norman Wolkove and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and Food and Chemical Toxicology.

In The Last Decade

David Préfontaine

16 papers receiving 709 citations

Peers

Countries citing papers authored by David Préfontaine

Since Specialization

Citations

This map shows the geographic impact of David Préfontaine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Préfontaine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Préfontaine more than expected).

Fields of papers citing papers by David Préfontaine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Préfontaine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Préfontaine. The network helps show where David Préfontaine may publish in the future.

Co-authorship network of co-authors of David Préfontaine

This figure shows the co-authorship network connecting the top 25 collaborators of David Préfontaine. A scholar is included among the top collaborators of David Préfontaine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Préfontaine. David Préfontaine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	<p>Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p> 2019 ·International Journal of COPD ·Alan Kaplan, Kenneth R. Chapman, (unknown), Irvin Mayers, (unknown), Michel Djandji, David Préfontaine, Andrew McIvor	11
2	Six Minute Walk Distance Is a Predictor of Survival in Patients with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation 2015 ·Canadian Respiratory Journal ·Esther Dajczman, (unknown), Goulnar Kasymjanova, David Préfontaine, Marc Baltzan, Norman Wolkove	50
3	Using a Virtual Game System to Innovate Pulmonary Rehabilitation: Safety, Adherence and Enjoyment in Severe Chronic Obstructive Pulmonary Disease 2013 ·Canadian Respiratory Journal ·(unknown), Esther Dajczman, Nathan Yang, Marc Baltzan, David Préfontaine, (unknown), (unknown), (unknown), Norman Wolkove	36
4	Changing Demographics Of Patients With COPD Admitted To A Sub-Acute Pulmonary Rehabilitation Unit 2012 ·David Préfontaine, Esther Dajczman, (unknown), (unknown), Marc Baltzan, Norman Wolkove	1
5	Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8+T cells in chronic obstructive pulmonary disease 2011 ·Respiratory Research ·Jessica Nadigel, David Préfontaine, Carolyn J. Baglole, François Maltais, Jean Bourbeau, David H. Eidelman, Qutayba Hamid	74
6	Children with atopic histories exhibit impaired lipopolysaccharide‐induced Toll‐like receptor‐4 signalling in peripheral monocytes 2010 ·Clinical & Experimental Allergy ·David Préfontaine, (unknown), Pierre Fiset, (unknown), Jella An, Monty B. Mazer, Qutayba Hamid, Bruce Mazer	20
7	Interleukin-33 in asthma: insights into pro-inflammatory roles of airway structural cells 2010 ·Allergy Asthma and Clinical Immunology ·David Préfontaine, (unknown), (unknown), Séverine Audusseau, Stéphane Lajoie-Kadoch, Ronald Olivenstein, Jamila Chakir, Andrew J. Halayko, Catherine Lemière, James G. Martin, Q Hamid	1
8	Atopy affects LPS responsiveness and TLR-4 expression in children peripheral mononuclear cells 2010 ·Allergy Asthma and Clinical Immunology ·David Préfontaine, (unknown), (unknown), (unknown), Qutayba Hamid, (unknown)	1
9	Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells 2009 ·The Journal of Immunology ·David Préfontaine, Stéphane Lajoie-Kadoch, Susan Foley, Séverine Audusseau, Ron Olivenstein, Andrew J. Halayko, Catherine Lemière, James G. Martin, Qutayba Hamid	446
10	Epithelium‐derived chemokines induce airway smooth muscle cell migration 2009 ·Clinical & Experimental Allergy ·Naoya Takeda, Yuki Sumi, David Préfontaine, (unknown), (unknown), Wisam Al-Ramli, (unknown), James G. Martin, Qutayba Hamid	31
11	Images in allergy and immunology: Regulatory T cells in allergic disease 2007 ·Journal of Allergy and Clinical Immunology ·Susan Foley, David Préfontaine, Michelle L. D’Antoni, Qutayba Hamid	2
12	Transcription factors in allergic diseases 2007 ·Journal of Allergy and Clinical Immunology ·David Préfontaine, Pierre Fiset, Qutayba Hamid	1
13	Airway epithelial cells in asthma 2007 ·Journal of Allergy and Clinical Immunology ·David Préfontaine, Qutayba Hamid	12
14	Images in allergy and immunology: Role of eosinophils in airway remodeling 2007 ·Journal of Allergy and Clinical Immunology ·Susan Foley, David Préfontaine, Qutayba Hamid	17
15	Th2 Inflammation reduces Toll-Like Receptor 4 Expression and Regulatory Functions of T Cells 2007 ·Journal of Allergy and Clinical Immunology ·David Préfontaine, Monty B. Mazer, (unknown), (unknown), Bruce Mazer, Qutayba Hamid	1
16	In vitro bioactivity of combustion products from 12 tobacco constituents 2005 ·Food and Chemical Toxicology ·David Préfontaine, André Morin, Catherine Jumarie, A.J. Porter	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact